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Amyloid P component (AP) 1 is a glycoprotein found in all forms of amyloid deposit 
regardless  of the  chemical  nature  of the  fibril  protein  (1-6).  It  is  indistinguishable 
from  a  normal  plasma  protein,  serum  amyloid  P  component  (SAP),  in  terms  of 
antigenicity,  molecular weight,  polypeptide subunit  composition, appearance  in the 
electron microscope, and the partial  amino acid sequences available hitherto  (7-11). 
SAP/AP is also a normal tissue protein in man; it is an integral constituent of vascular 
basement  membranes,  where it  is covalently linked to collagen and/or other matrix 
glycoproteins  (12),  and  is  located  on the  peripheral  microfibrillar  mantle  of elastic 
fibres  throughout  the  body  (5). 2 SAP  is  very closely related  to  C-reactive  protein 
(CRP), the classical acute-phase reactant  (13), and there is ~60% homology of amino 
acid  sequence  between  them  in  man  (14).  CRP  and  SAP  are  both  composed  of 
noncovalently associated  subunits  arranged  with cyclic pentameric  symmetry in an 
annular  disclike  configuration,  and  both  proteins  have  the  capacity  for  calcium- 
dependent  ligand binding (10,  14,  15).  The ligands for SAP identified so far include 
amyloid  fibrils  (16),  agarose  (10),  and  some  other  polysaccharides  (17),  and  fixed 
complement (18), but the physiological role and possible pathogenetic significance of 
SAP/AP are not known. 
We have previously reported that proteins that very closely resemble human SAP 
in  terms  of molecular  structure  and  binding  specificity  for  agarose  are  present  in 
mammals and in lower vertebrates,  including fish  (19). There is  ~50% homology of 
amino  acid  sequence  in  the  N-terminal  region  between  SAP of plaice  (Pleuronectes 
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platessa L.) and man (20). The stable conservation of structure and binding reactivity 
of this  protein  throughout  vertebrate  evolution  suggests  that  SAP  has  important 
functions and that these may relate to its ligand-binding properties. We have therefore 
investigated  the  binding  specificity of human  SAP for normal  serum  proteins  and 
report  here  that,  under  suitable  conditions,  SAP,  in  the  presence  of calcium  ions, 
selectively binds two distinct  proteins from whole human serum. We have identified 
these as fibroneetin (Fn) and C4-binding protein (C4bp) and have shown that pairing 
of SAP molecules is required for them to bind Fn. 
Materials and Methods 
Proteins.  Isolated pure Fn (21) and SAP (10) were prepared from citrated human plasma 
and normal human serum (NHS), respectively, according to established methods. To ensure as 
far as possible the complete purity of the SAP used here, the protein,  isolated as previously 
described (10), was passed over a column of Sepharose to which polyvalent anti-NHS antibodies 
were coupled, and it was then gel filtered on Sephacryl S-300 (Pharmacia G. B. Ltd., Hounslow, 
Middlesex, England). No contaminants were detectable by immunoelectrophoresis and crossed 
immunoelectrophoresis against polyvalent anti-NHS, by gradient polyacrylamide gel electro- 
phoresis (PAGE) of the native protein or by sodium dodecyl sulphate (SDS)-PAGE (see below) 
with a 200 #g sample. Human IgM was isolated from a macroglobulinemia serum by repeated 
euglobulin precipitation, followed by gel filtration on Sephadex G-200 (Pharmacia).  Isolated 
purified C4bp (22) was kindly provided by Dr. Victor Nussenzweig, New York University, and 
isolated human a2-macroglobulin (23) was provided by Dr. A. J. Barrett, Strangeways Labo- 
ratory, Cambridge, England. Bovine serum albumin (BSA) was obtained from Sigma Chemical 
Co. Lt., Poole, Dorset, England. 
Antisera.  Monospecific antisera to SAP, Fn, and C3 (24) were raised by immunization of 
rabbits  and  sheep with  the  isolated  proteins.  Polyvalent anti-NHS was raised  by repeated 
immunization of sheep with  NHS.  Serum  proteins that  were bound by SAP-Sepharose (see 
below)  were used  to immunize a  rabbit.  Monospecific rabbit  anti-C4bp  serum  was kindly 
provided by Dr. Victor Nussenzweig. The IgG1 fractions of normal sheep serum and of sheep 
antisera to SAP and C3 were isolated by salt fractionation and DEAE cellulose chromatography. 
The IgG fraction of rabbit anti-Fn serum was isolated using protein A-Sepharose (Pharmacia 
G. B. Ltd.) according to the manufacturer's instructions. Antisera to fibrinogen, Factor XIII, 
Factor VIII, transferrin, a2-macroglobulin, a  and fl lipoproteins, C ls, C lq, C4, IgM, IgA, and 
IgG were obtained from Behring Diagnostic Reagents, Hoechst Pharmaceuticals, Hounslow, 
Middlesex, England. 
Immobilized Proteins.  Sepharose 4B and CNBr-activated Sepharose 4B were obtained from 
Pharmacia, and various proteins were coupled to the latter generally according to the manu- 
facturer's instructions.  IgG fractions of different antisera were coupled in pH  7.0 phosphate 
buffer at between 1 and 10 mg/ml of beads to produce, respectively, anti-SAP-Sepharose, anti- 
C3-Sepharose, anti-Fn-Sepharose, and normal sheep IgG-Sepharose. SAP, BSA, and Fn were 
coupled in pH 9.0 carbonate buffer. After coupling SAP to CNBr-Sepharose at between 0.1 
and  10 mg/ml of beads, the beads were washed with 0.1 M  borate buffer, pH 8.0, containing 
1.0 M  NaC1.  SAP-Sepharose was not washed  at  pH  4.0 because  SAP is labile  at  low pH. 
Control beads were prepared by blocking the active groups on CNBr-Sepharose with ethanol- 
amine  without  coupling any protein.  Fn  was coupled to Sepharose  at  4  mg/ml  of beads. 
Gelatin-Sepharose (4 mg gelatin/ml beads) was prepared as described elsewhere (21) and was 
loaded with Fn by passing  100 ml of fresh citrated normal plasma over a  15-ml column and 
then washing with phosphate-buffered saline (PBS), pH 7.2, containing 0.01 M  citrate. 
Human Serum.  Fresh NHS was obtained by allowing venous blood from laboratory volunteers 
to clot at room temperature for 2-4 h before centrifugation. In some experiments, serum from 
a single donor was used, in others different sera were pooled. In some cases benzamidine  (5 
raM) and phenylmethylsulphonyl fluoride (PMSF) (10 mM) (both from Sigma Chemical Co.) 
were added to the serum as soon as it was separated. Fn-depleted NHS was prepared by passing 
fresh citrated plasma over gelatin-Sepharose and then over anti-Fn-Sepharose before recalci- 1136  SERUM  AMYLOID P COMPONENT  BINDS FIBRONECTIN  AND C4bp 
fying it and allowing it to clot. Absence of Fn from the serum was confirmed by electroimmu- 
noassay. SAP-depleted NHS was prepared by passing NHS over plain unsubstituted Sepharose 
that had been equilibrated with Tris-saline-Ca (10). The absence of SAP from the serum was 
confirmed by electroimmunoassay. 
Immunochemical Assays.  Proteins were detected and identified by double immunodiffusion  in 
1% wt:vol agarose gel (Indubiose A37, IBF S.A., Clichy, France) in 0.075 M veronal buffer, pH 
8.6,  containing 0.01 M  EDTA.  Electroimmunoassays for  SAP,  C4bp,  C3,  and  Fn  were 
performed  by  established  techniques  using monospecific antisera  (25). These  assays  were 
calibrated using standards of the isolated pure proteins. IgM, IgA, and IgG were quantitated 
by radial immunodiffusion  with a standard serum (Behring Diagnostics) for calibration. 
PAGE.  Gradient PAGE analysis of native proteins was performed in 4-30% gradient gels 
(Pharmacia)  run  exactly  according to  the  manufacturer's instructions. Standard  globular 
proteins used as markers; thyroglobulin, 669,000  mol wt;  ferritin, 440,000  mol wt; catalase, 
232,000  mol wt; lactate dehydrogenase, 140,000 mol wt; and albumin, 67,000  mol wt, were 
obtained from Pharmacia. SDS-PAGE analysis was undertaken in slab gels using the method 
of Laemmli  (26). Marker  polypeptides were  fibronectin, 220,000-225,000  mol  wt,  and et2- 
macroglobulin, 181,000 mol wt, and the Pharmacia kit of phosphorylase b, 94,000  mol wt; 
albumin, 67,000 mol wt; ovalbumin, 43,000 mol wt; and carbonic anhydrase, 30,000 mol wt. 
Stained gels were examined in a Helena QuickScan scanning  densitometer (T & J Crump Ltd., 
Rayleigh, Essex,  England) to quantitate the distribution of protein among different bands. 
Two-dimensional SDS-PAGE was performed using 2.5-mm Diam  7.5% rod gels in the first 
dimension. Samples were run on these without reduction in the Pharmacia GE4 apparatus and 
the whole gels were then immersed and incubated in the Laemmli sample buffer (26), including 
2-mercaptoethanol, for 1 h at 37°C before being applied horizontally at the top of a 7.5% slab 
gel. After electrophoresis into the second dimension, the rod was discarded and the slab gel was 
stained. Replicate rod gels were stained after the first electrophoresis. 
Affinity Chromatography Experiments.  Tests for the binding  of serum proteins to affinity media 
were  performed  at  4°C  using either  column or  batch  procedures.  With  the  exception of 
experiments involving uptake of Fn onto gelatin-Sepharose, the Sepharose beads were always 
pre-equilibrated in 0.01  M  Tris-buffered 0.14  M  saline, pH 8.0, containing 0.002  M  calcium 
chloride (Tris-saline-Ca) and isolated proteins were dialyzed into this buffer before use. Serum 
or isolated proteins were passed over or incubated with the affinity media, which were then 
washed with Tris-saline-Ca until no further material absorbing at  280 nm was eluted. The 
beads were finally eluted with Tris-saline containing 0.01 M  EDTA instead of calcium (Tris- 
nm assummgEa~m  -- 13. In  saline-EDTA), and the eluate was monitored by absorbance at 280  •  a% 
experiments with  isolated Fn, the  quantities bound and eluted were  measured by specific 
electroimmunoassay.  When required for PAGE analysis, the EDTA eluates from SAP-Sepharose 
and anti-SAP-Sepharose columns were  concentrated on  PM30  membranes in the  Amicon 
Diaflo system (Amieon Corp., Lexington, Mass.). To determine whether Fn in the EDTA eluate 
obtained after NHS had been passed over SAP-Sepharose retained its affinity for gelatin, 5.5 
ml of eluate  (A~0 =  0.39)  was passed over a  2-ml column of gelatin-Sepharose. Unbound 
protein was pooled and concentrated to 4 ml with A~o =  0.15. The column was washed with 
Tris-saline-EDTA  and then eluted with 1.0 M arginine, pH 7.2, to yield 5 ml with A~0 = 0.15. 
Starting material, absorbed and eluted protein were compared in gradient PAGE. 
Digestion with T~ypsin.  Samples of EDTA eluate off SAP-Sepharose were dialyzed into Tris- 
saline-Ca and then incubated at 37°C for 5 min with 4% wt:wt trypsin (Sigma type XI). The 
reaction mixture was then run immediately in gradient PAGE. 
Immunoprecipitation  Experiments.  40 #g  of the  mixture of serum  proteins that  underwent 
calcium-dependent binding by SAP-Sepharose were radiolabeled to a specific activity of 7.15 
mCi/mg using Na125I (IMS30;  Radiochemical Centre, Amersham, Bucks,  England) in the 
chloramine T  method (27). Separate 20-#1 vol, containing 1.6 #g of the labeled material, were 
mixed with 20-#1 vol of monospecific antisera to Fn and to C4bp and normal rabbit serum as 
a control. After incubation together on ice for  10 min, 100 #1 volumes of a 40% suspension of 
fixed Staphylococcus aureus particles in PBS with 0.01 M EDTA were added. After mixing and a 
further incubation for  10 min the suspensions were centrifuged and washed twice in PBS/ 
EDTA containing 0.05% desoxycholate. The sedimented S. aureus were then eluted by boiling DE  BEER  El"  AI,.  1137 
with the SDS-PAGE sample buffer containing mercaptoethanol (26), and the eluates were run 
in SDS-PAGE. The slab was stained, dried, and subjected to autoradiography using LKB aH- 
Ultrofilm (LKB Instruments Ltd., London, England). In other experiments, monospecific anti- 
Fn and anti-C4bp antisera were used in optimal proportions titrations against a pool of fresh 
NHS. The optimal amount of each antiserum, which precipitated all the respective specific 
antigen, was then added to aliquots of NHS in  the presence and absence of 0.01 M  EDTA. 
After incubation at 21°C for 1 h and overnight at 4°C, the concentration of SAP in the starting 
material and  in  the  treated  samples was  measured.  Complete depletion  of Fn  and  C4bp, 
respectively,  was confirmed by specific electroimmunoassay. 
Results 
Calcium-dependent Binding of Serum Proteins by SAP-Sepharose.  The capacity of SAP to 
bind serum proteins was tested by passing fresh NHS over a column of SAP-Sepharose 
prepared  by covalent  conjugation  of isolated  pure  SAP  to CNBr-Sepharose.  After 
washing with Tris-saline-Ca until  the effluent had zero absorbance at  280  nm, the 
column was eluted with Tris-saline-EDTA and the recovered proteins were quanti- 
tated and analyzed. The same procedure was adopted with control columns of BSA- 
Sepharose and ethanolamine-Sepharose.  In many separate experiments, columns of 
SAP-Sepharose always yielded more protein in the EDTA eluate than either of the 
control columns and a representative result is shown in Table I. 
Characterization by PAGE of the Serum Proteins Bound by SAP-Sepharose.  PAGE analysis 
of the serum proteins that were bound by SAP-Sepharose in the presence of calcium 
ions and eluted with EDTA revealed two major constituents that were the same in all 
the different preparations obtained by this procedure. In contrast, EDTA eluates from 
the control  columns produced  only a  single faint  band of SAP,  which  is known  to 
have calcium-dependent  binding  affinity  for  agarose  (10).  In  gradient  PAGE  run 
under nondenaturing conditions (Fig. 1), there was: (a) material of very high apparent 
molecular weight, which penetrated poorly into the 4% polyacrylamide at the top of 
the gel and did not form distinct bands, and (b) material forming a closely spaced set 
of two  or  three  distinct,  sharply  focused  bands  with  apparent  molecular weights 
around  730,000  mol  wt  by  comparison  with  the  migration  of standard  globular 
protein markers. In three separate preparations, the distribution  of the total protein 
between a  and b  was 42.3  ±  5.7%  (mean +  SD)  in the very high molecular weight 
material  and  41.5  ±  4.2%  in  the  730,000  mol wt  bands.  In  addition,  there  was  a 
TABLE  I 
Calcium-dependent Binding of Strum Proteins by SAP-Sepharose 
Volume of serum 
offered 
Total protein eluted with EDTA 
SAP-Sepha-  BSA-Sepharose:~  Ethanolamine- 
rose*  Sepharose~ 
ml  mg 
5  1.5  NDII  ND 
20  2.6  NI)  ND 
60  2.6  0.3  0.1 
* 13.2 mg SAP coupled to 3.5 ml of CNBr-Sepharose. 
:~ 14 mg BSA coupled to 3.5 ml of CNBr-Sepharose. 
§ 3.5 ml CNBr-Sepharose blocked with ethanolamine, no protein coupled. 
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Fio.  1.  4-30%  gradient  PAGE of proteins eluted with EDTA after passage of NHS over SAP- 
Sepharose. The two major constituents are designated a and b.  Positions of marker proteins of 
known molecular weight are indicated by arrows. 
Fro.  2.  7.5%  SDS-PAGE of  proteins eluted with EDTA after passage of NHS over SAP-Sepharose. 
Track 1, nonreduced proteins showing two main bands of high apparent molecular weight; track 2, 
reduced proteins showing pair of bands at 220,000-225,000 mol wt and poorly focused set of bands 
at about  70,000 mol wt. Positions of marker proteins of known molecular weight are indicated by 
arrows. 
fainter  band  at  an  apparent  molecular  weight  of 647,000,  which  comprised  9.7  + 
6.0% of the total protein. 
Analysis of these preparations without reduction in SDS-PAGE again revealed two 
major components:  a  closely spaced  pair of bands  with  apparent  molecular weight 
greater than 500,000, and a  single band at 450,000  (Fig.  2, track  1). After reduction, 
these proteins yielded a  well defined pair of bands at 220,000-225,000,  and a  poorly 
focused set of bands at  ~70,000  (Fig.  2, track 2).  Two-dimensional SDS-PAGE (not 
shown)  revealed  that  the  220,000-225,000  bands  were  derived  from  the  450,000 
protein,  and  the  70,000  subunits  were  derived  from  the  higher  molecular  weight 
material. 
The sizes and polypeptide chain compositions of the two serum proteins bound by 
immobilized  SAP corresponded with  the known structures  of Fn  (28-31)  and C4bp 
(22),  respectively.  Fn and  C4bp,  which had  been  isolated  separately  by established 
techniques  (21,  22),  were  therefore  run  as  standards  for comparison  in  the  various 
PAGE  systems  (Figs.  3  and  4)  and  they  clearly  identified  precisely  with  the  two DE  BEER  ET  AL.  1139 
Fro. 3.  4-30%  gradient PAGE. Track  1, isolated pure Fn; track 2, isolated pure C4bp; track 3, 
proteins eluted with EDTA after passage of NHS over SAP-Sepharose;  track 4, proteins eluted with 
EDTA after passage of Fn-depleted NHS over SAP-Sepharose. Position of marker proteins of known 
molecular weight are indicated by arrows. 
Fro. 4.  5.5% SDS-PAGE. Samples in tracks 1-4 were not  reduced; tracks 5-8,  reduced with 
mercaptoethanol. Tracks 1 and 5, isolated pure C4bp; tracks 2 and 6, isolated pure Fn; tracks 3 and 
7, proteins eluted with EDTA after passage of Fn-depleted NHS over SAP-Sepharose; tracks 4 and 
8, proteins eluted with EDTA after passage of NHS over SAP-Sepharose. Positions of marker 
proteins of known molecular weight are indicated by arrows. 
proteins in question. It is evident that both Fn and C4bp in the native state run with 
anomalously high apparent molecular weights in gradient gels. 
Immunochemical  Identification  of  the  Strum  Proteins  Bound  by  SAP-Sepharose.  Im- 
munoprecipitation in agarose gel with monospecific antisera to Fn and C4bp, respec- 
tively, confirmed the presence of these two proteins in the material eluted from SAP- 
Sepharose (Fig. 5). Furthermore, immunization  with the eluted material induced the 
production of an antiserum giving two distinct precipitation lines against the eluate 
and these were identified as being anti-Fn and anti-C4bp, respectively (Fig. 5). 
To correlate the immunochemical identity of the two proteins with their polypep- 1140  SERUM  AMYLOID P  COMPONENT  BINDS  FIBRONECTIN AND C4bp 
Fro.  5.  Immunodiffusion  in agarose gel between  1, proteins eluted with EDTA after passage of 
NHS over SAP-Sepharose; 2, monospecific rabbit anti-Fn serum; 3, rabbit antiserum raised against 
the proteins in 1; 4, monospecific rabbit anti-C4bp serum; 5, isolated pure C4bp;  6, isolated pure 
Fn. 
Fxc. 6.  Autoradiograph of reduced 7.5% SDS-PAGE analysis of proteins eluted with EDTA after 
passage of NHS over SAP-Sepharose. The eluate was radioiodinated and immunoprecipitated with 
1, monospecific anti-Fn; 2, monospecific anti-C4bp;  3, normal rabbit serum control; track 4, whole 
nonprecipitated radiolabeled eluate. The positions of known marker proteins run in the same gel 
are indicated by arrows. 
tide chain composition, a  preparation of the eluate from  SAP-Sepharose was radio- 
labeled  and  then  immunoprecipitated  in  separate  aliquots  with  anti-Fn  and  anti- 
C4bp antisera. After washing, denaturation, and reduction, the precipitates were run 
in  an  SDS-PAGE  slab  gel,  which  was  then  subjected  to  autoradiography  (Fig.  6). 
This  showed  that  anti-Fn  antibodies  had  reacted  selectively with  the  protein  at 
220,000-225,000  and  that  anti-C4bp  antibodies had  selectively complexed with the 
protein composed of 70,000  mol wt  subunits.  Traces of Fn  in the anti-C4bp immu- 
noprecipitate were also visible in the normal nonimmune  rabbit serum control (Fig. 
6)  and  are  due  to  binding of Fn  to  the  S.  aureus particles  (32)  used  to  harvest  the 
immune precipitates. 
Trace Constituents of the Material Eluted  from  SAP-Sepharose.  Although Fn and C4bp 
were always the major proteins eluted from  SAP-Sepharose, other faint bands were 
seen in some preparations analyzed by PAGE techniques and in the autoradiograph DE  BEER  ET  AL.  1141 
of the radiolabeled eluate. Many of these bands were derived by cleavage of Fn, which 
is known for its susceptibility to proteolytic degradation  (30,  31).  During storage of 
eluates at 4°C, there was progressive loss of staining from the band(s) corresponding 
to intact Fn and appearance of new bands at lower apparent molecular weights. This 
process was retarded by adding benzamidine and PMSF to the preparations. On the 
other hand,  incubation with trypsin caused complete loss of the intact  Fn band but 
had no effect on the C4bp. 
In addition to the cleavage fragments of Fn, presumably generated by proteinases 
released or activated in  serum, trace amounts of certain other serum proteins were 
detected  immunochemically  in  the  eluates.  These  proteins,  which  together  never 
exceeded  10% of the total protein  present, were IgM, IgG, IgA, C3,  Clq,  Cls,  and 
SAP itself. With  the exception of IgM, comparable amounts of these proteins were 
recovered in the EDTA eluates from the control, non-SAP-bearing Sepharose columns. 
More IgM was always eluted from SAP-Sepharose and, although it never comprised 
more than  10% of the total protein, it was sometimes identifiable in SDS-PAGE (Fig. 
7).  Traces of C4  were  detected  in  the  eluate  from SAP-Sepharose  only when  aged 
serum  instead  of fresh  NHS  was  used  as  the  starting  material.  This  was  probably 
FIG. 7.  7.5%  SDS-PAGE  of reduced proteins eluted with EDTA after passage of NHS over SAP- 
Sepharose. Positions of marker proteins of known molecular weight, including IgM heavy chain 
~), are indicated by arrows. 
Fro. 8.  4-30%  gradient PAGE. Track 1, proteins eluted with EDTA after passage of NHS over 
SAP-Sepharose; track 2, same material as 1  after absorption with gelatin-Sepharose;  track 3, protein 
eluted off gelatin-Sepharose  with 1.0M arginine. 1142  SERUM  AMYLOID P COMPONENT BINDS FIBRONECTIN AND C4bp 
because some C4b that was generated during aging was bound by C4bp (22), which 
in turn was bound by the immobilized SAP. 
Binding of Fn by SAP-Sepharose.  The EDTA eluate obtained after NHS had been 
passed over SAP-Sepharose contained Fn, which retained its characteristic ability to 
bind to gelatin (33). Passage of the mixture of proteins eluted by EDTA (Fig. 8, track 
1)  over a  column of gelatin-Sepharose selectively removed the Fn  (Fig. 8, track 2), 
which was then recovered by elution with  1 M  arginine (Fig. 8, track 3)  (21). 
Isolated pure Fn was also bound by SAP-Sepharose. An excess of purified Fn in 
Tris-saline-Ca was passed  over 3.5  ml of Sepharose to which  13.2  mg of SAP had 
been coupled and 3.0 mg of Fn became bound. Elution with EDTA recovered all the 
bound Fn, whereas no Fn became bound to or was eluted from the control, BSA- 
Sepharose, or ethanolamine-Sepharose columns. There was therefore a specific inter- 
action between Fn and SAP-Sepharose that was calcium dependent but independent 
of any other protein or serum constituent. 
All the known ligand-binding reactivities of SAP are calcium dependent  (10,  15, 
16), whereas the binding of Fn to proteins such as collagen, gelatin, and fibrin (28- 
31)  and  hemagglutination  by human  plasma  Fn  (34)  are  independent  of divalent 
cations. The present results therefore suggested that in these experiments SAP was the 
binding protein and Fn was the ligand. 
Immobilized Fn Does Not Bind Soluble SAP.  Fn was immobilized by directly coupling 
the  isolated  pure  protein  to  CNBr-Sepharose  or  by  passing  an  excess of citrated 
plasma  over  a  column  of gelatin-Sepharose.  Both  types  of  material  were  then 
equilibrated with Tris-saline-Ca, and fresh NHS, as a source of SAP, was passed over 
them.  After  further  washing  with  Tris-saline-Ca,  elution  with  Tris-saline-EDTA 
yielded no more SAP than was yielded by plain unsubstituted Sepharose beads that 
had been exposed to NHS in the same way. The interaction between Sepharose-SAP 
and Fn thus seems to depend on the molecular disposition of SAP when it is coupled 
to Sepharose. 
SAP in Serum Is Not Complexed with Fn or C4bp.  An alternative explanation for the 
failure of SAP in serum to become bound to immobilized Fn is that SAP, in its native 
state in the serum, may already be complexed with Fn and/or C4bp, or possibly some 
other ligand, and that  it may not dissociate from such complexes and attach to the 
solid-phase  Fn  under  the  conditions  tested.  The  existence of such  complexes was 
therefore sought  by adding  optimal  amounts  of monospecific antisera  to  Fn  and 
C4bp, respectively, to samples of normal serum. All the Fn and C4bp were precipi- 
tated, as confirmed immunochemically, but there was no depletion of SAP irrespective 
of whether  the  precipitations  were  conducted  in  the  presence of calcium  ions  or 
EDTA.  This is strong evidence against  the existence of a  significant proportion of 
native SAP in the form of calcium-dependent complexes with either Fn or C4bp. 
Calcium-dependent  Binding  of  Fn  and  C4bp  from  Serum  Passed  over Anti-SAP- 
Sepharose.  The capacity of SAP  to  bind  serum  proteins was  also  investigated  by 
passing normal serum over anti-SAP antibodies coupled to CNBr-Sepharose. SAP in 
the serum was  absorbed by the anti-SAP  antibodies, and  after washing with Tris- 
saline-Ca the column was eluted with EDTA. A  significant amount of protein was 
recovered (Table II)  and consisted of a  mixture of Fn  and  C4bp exactly as in the 
eluate from SAP-Sepharose. Control columns of normal IgG-Sepharose and of anti- 
C3-Sepharose yielded no Fn or C4bp whatsoever, only a small quantity of SAP itself, DE  BEER  ET  AL. 
TABLE II 
Calcium-dependent Binding of Serum Proteins by Anti-SAP-Sepharose 
Total protein eluted with EDTA 
Volume of serum 
offered  Anti-SAP-  Normal IgG-  Anti-C3-Sepha- 
Sepharose*  Sepharose:~  rose~ 
ml  mg 
60  3.6  0.8  0.9 
* 80 mg of IgGl fraction of  sheep anti-SAP coupled to 15 ml CNBr-Sepharose. 
This column removed all the SAP (2.9 mg) from the serum passed over it. 
:~ 80  mg of IgG1  fraction of normal sheep serum coupled to  15  ml CNBr- 
Sepharose. 




Calcium-dependent Binding of Serum Proteins to SAP-Sepharose* 
Amount of SAP coupled (mg/ml Sepharose beads)  0  0.1  0.5  1.0  10.0 
Total protein eluted with EDTA (mg)  0.05  0.07  0.08  0.14  0.61 
* 10 ml vol of NHS were offered to separate 1.0 ml vol of Sepharose bearing the amounts of SAP shown. 
and  trace  amounts  of immunoglobulins,  C1  and  C3.  The specific role of SAP  in 
binding Fn and C4bp when NHS was passed over anti-SAP-Sepharose was confirmed 
by using SAP-depleted NHS.  NHS  that  had  been completely depleted of SAP by 
absorption with plain Sepharose (10) was passed over the anti-SAP-Sepharose column. 
After washing with Tris-saline-Ca, elution with EDTA yielded only traces of protein 
and no detectable Fn or C4bp. However, when this same serum was then passed over 
SAP-Sepharose and  followed by washes of Tris-saline-Ca, elution with EDTA pro- 
duced the mixture of Fn and C4bp exactly as before. 
When identical aliquots of NHS were used as starting material, more Fn and C4bp 
were always recovered from anti-SAP-Sepharose than  from SAP-Sepharose.  In  the 
representative experiments shown in Tables I and II, the yields of eluted protein from 
SAP complexed by anti-SAP-Sepharose and directly coupled to Sepharose were 1.24 
mg/mg and 0.12 mg/mg, respectively. 
In view of the failure of anti-Fn or anti-C4bp antibodies added to NHS to deplete 
any SAP at all, the results with the anti-SAP-Sepharose column cannot be adduced 
as evidence that SAP in serum is complexed with these proteins. Rather it seems that 
when SAP molecules are either immobilized or aggregated in some way, they acquire 
a  calcium-dependent reactivity with Fn and C4bp.  Binding of SAP by solid-phase 
anti-SAP antibodies appears to generate this reactivity much more efficiently than 
direct coupling of SAP to Sepharose. 
Aggregation of SAP Molecules Is Required for Them to Bind Fn and C4bp.  When serum 
was  passed  over plain  unsubstituted  Sepharose,  the  SAP was  taken  up,  due to its 
calcium-dependent  affinity  for  agarose  (10),  but  no  Fn  or  C4bp  was  yielded  by 
subsequent  elution with EDTA.  The capacity of plain  Sepharose beads for SAP is 
only ~60 #g/ml (16), and when serum was incubated with batches of SAP-Sepharose 
to which different amounts of SAP had been coupled, there was no significant yield 
of Fn and C4bp from beads bearing < 1 mg SAP/ml (Table III). This suggests that 1144  SERUM  AMYLOID P COMPONENT BINDS FIBRONECTIN AND C4bp 
mere immobilization of SAP is not sufficient for it  to express reactivity for Fn and 
C4bp and that there may be a need for close association of SAP molecules. 
This  suggestion  is  supported  by the  high  relative  efficiency of binding  by SAP 
complexed with anti-SAP-Sepharose (Tables I and II). The IgG fraction of anti-SAP 
serum that was used here contained only -5% of specific anti-SAP antibodies and it 
was coupled at  5 mg/ml of beads, well  below their capacity of 20 mg/ml or more. 
Anti-SAP molecules were therefore probably spaced out on the bead surfaces rather 
than being close to each other, and  the greatest  degree of aggregation of SAP that 
could  have  occurred would  have  been  binding  of pairs  of SAP  molecules  by  the 
adjacent  combining sites of divalent  anti-SAP IgG molecules.  Alternatively, it  was 
possible that the mere binding of individual SAP molecules by immobilized anti-SAP 
might be sufficient for the SAP, in turn, to express its binding reactivity for Fn and 
C4bp. 
Pairs of SAP Molecules Bind Fn.  Anti-SAP-Sepharose beads bearing 5 mg anti-SAP 
IgG fraction/ml of beads were divided into  1-ml  and  10-ml portions, and the same 
volume of NHS was incubated with  each portion in  a  batch procedure.  Sufficient 
SAP was provided by the NHS to completely saturate the smaller portion. The larger 
one received only  10% of its capacity and the bound SAP molecules were therefore 
presumably widely scattered  on the bead  surfaces.  After washing with  EDTA and 
reequilibration with Tris-saline-Ca, only the beads that were saturated with SAP were 
capable of binding isolated  pure  Fn  (Table  IV),  despite  the  fact  that  both sets of 
beads bore the same total amount of immobilized SAP. 
In another experiment,  two  lots of 10 mg of the  IgG fraction of anti-SAP were 
coupled, respectively, to 1 ml and 10 ml of CNBr-Sepharose. The spacing of anti-SAP 
molecules  on  these  two  lots  of beads  must  have  been  widely  different  but  after 
saturating  them  with  an  excess  of isolated  SAP,  both  had  the  same  capacity  for 
binding isolated Fn (Table V). 
These results indicate that the capacity of SAP to bind Fn is expressed when two 
SAP molecules are near each other. This can be achieved either by directly coupling 
a  high density of SAP to CNBr-Sepharose, or by providing sufficient  SAP to anti- 
SAP-Sepharose for two SAP molecules to be taken up by each antibody, regardless of 
how widely spaced the anti-SAP molecules are.  The quantitative data in Tables IV 
TABLE IV 
Effect of Degree of Saturation of Anti-SAP-Sepharose with SAP on the 
Capacity of the SAP to Bind Fn * 
Anti-SAP  Percent  IgG cou-  Amount  capacity  Molar ratio  Volume of  pied  SAP  of Fn 
beads  for SAP  of SAP:Fn:[:  (mg/ml  bound 
of beads)  taken up 
ml  p.g  I~g 
1  5  130  100  153  2:1.3 
10  5  130  10  0  -- 
* Anti-SAP-Sepharose beads were either fully  or partially saturated with SAP 
and were then offered an excess of isolated pure Fn in Tris-saline-Ca for 
binding. 
:~ Based on molecular weights of 450,000 for Fn and 250,000 for SAP. DE  BEER  ET  AL.  1145 
TABLE  V 
Effect of Amount of Anti-SAP Coupled to Sepharose on the Capacity of SAP to 
Bind Fn * 
Anti-SAP  Percent 
IgG cou-  capacity  Amount  Molar 
Volume of  pied  SAP  of Fn  ratio of 
beads  (mg/ml  for SAP  bound  SAP:Fn~ 
of beads)  taken up 
ml  lag  #g 
1  10  330  100  318  2:1 
10  1  292  100  318  2:1.2 
* Anti-SAP-Sepharose beads bearing either 10 or 1 mg anti-SAP IgG/ml were 
fully saturated with SAP and then offered an excess of isolated pure Fn in 
Tris-saline-Ca for binding. 
Based on molecular weights of 450,000 for Fn and 250,000 for SAP. 
and  V  also  indicate  that  each  pair  of SAP  molecules  usually  binds  a  single  Fn 
molecule. 
Independent and Competitive Binding of Fn and C4bp by Aggregated SAP.  When serum 
was depleted of Fn by passage over gelatin-Sepharose and then over anti-Fn-Sepharose 
before being offered to a column of SAP-Sepharose, the resultant EDTA eluate of the 
SAP column contained double the usual proportion of C4bp (82 vs. 42% of the total 
protein)  (Figs.  3  and  4)~ The  binding  of C4bp  was  therefore independent  of the 
presence of Fn and the two proteins seem to compete with each other for uptake by 
aggregated SAP. Presumably, each closely adjacent pair of SAP molecules is able to 
bind a molecule of either Fn or C4bp. 
Discussion 
We report here for the first time the specific calcium-dependent binding reactivity 
of SAP for two distinct normal serum proteins, Fn and C4bp. SAP in solution in the 
serum was not complexed with either of these proteins, but when SAP was directly 
coupled at a sufficient density to Sepharose beads, or was itself bound by immobilized 
anti-SAP  antibodies,  it became capable of selectively recognizing Fn  and  C4bp  in 
whole undiluted normal serum. The capacity of SAP to bind Fn was found to depend 
on  dimerization  of  SAP,  such  as  was  produced  by  allowing  divalent  anti-SAP 
molecules to bind pairs of SAP molecules. Uptake of Fn by SAP in this form required 
calcium ions but was independent of all other proteins or serum constituents. Similar 
considerations applied to the binding of C4bp and, although this was not tested with 
the isolated protein, it was shown to be independent of the presence of Fn. 
Both Fn and C4bp are proteins with their own well-defined binding reactivities. Fn 
binds  to collagen, gelatin, aetin,  fibrin, DNA,  glycosaminoglycans, glyeolipids, and 
cell surfaces of many cell types (28-31). C4bp binds very specifically to C4b, the major 
cleavage fragment of the complement component C4  (22, 35-37). However none of 
the reactions described hitherto of human plasma Fn with other proteins (28-31, 34) 
nor of C4bp with C4b requires calcium or any other divalent cations, even though 
C4bp does itself bind calcium ions (22). In contrast, all the binding properties of SAP 
reported  previously  are  absolutely  dependent  on  calcium  ions  (10,  15,  16).  This, 
together with our present observation of the failure of immobilized Fn to bind soluble 1146  SERUM  AMYLOID  P  COMPONENT  BINDS  FIBRONECTIN  AND C4bp 
SAP indicates that, in the associations we have described here, SAP is functioning as 
the binding protein and Fn and C4bp as the ligands. 
The basis  for the  specificity of the  reaction of aggregated  SAP  with  these  two 
disparate serum proteins is not known. There is no known similarity between Fn and 
C4bp, although it is possible that their carbohydrate moieties may be related. SAP is 
clearly able to bind to polysaccharides, agarose, for example (10), a  linear galactan 
hydrocolloid, and experiments are currently in progress to determine whether aggre- 
gated SAP binds the glycopeptides isolated after exhaustive proteolysis of purified Fn. 
In fact, the present observations provide the first opportunity to identify and char- 
acterize chemically potentially physiological ligand(s) for SAP. 
Studies of the formation of complexes of isolated fluid-phase SAP with Fn and with 
C4bp were not possible because in the presence of sufficient free calcium ions for SAP 
to express its binding reactivity, the  SAP  molecules aggregate on themselves  (16). 
However, density gradient ultracentrifugation studies using whole serum, the results 
of which  are to be reported elsewhere,  3 failed to show any evidence of interaction 
between soluble SAP and either Fn or C4bp under physiological conditions. 
C4bp  is  evidently an  important  regulatory protein  of the  classical  pathway  of 
complement activation  (35-38).  It is bound to antigen-antibody complexes in vitro 
and has been detected at sites of their in vivo deposition (39). Studies of the effects, if 
any, of SAP on the behavior and  function of C4bp and of the presence of SAP in 
antigen-antibody-complement complexes will be of considerable interest. 
We  have recently observed  that,  in  the  presence of calcium  ions,  isolated SAP 
agglutinates complement-coated erythrocytes (EAC)  (18).  The physiological signifi- 
cance of the reaction is not clear because it is inhibited by the presence of serum or 
even by human serum albumin at concentrations of 4 mg/ml or more.  4 Furthermore, 
when  EAC  are  generated  from  serum  as  the  source  of complement,  SAP  is  not 
detectable on the cells.  4 In  marked contrast, the reaction of aggregated SAP with 
soluble Fn and C4bp proceeds as well in serum as with the isolated proteins and is 
therefore more likely to relate to in vivo functions. 
The one well-established in vivo reactivity of SAP is its binding to amyloid fibrils 
(16).  AP is present in all forms of amyloid regardless of the chemical nature of the 
fibril proteins (1-6), and it can be eluted from the deposits by chelating agents (11). 
In preliminary immunohistochemical studies, we have not yet been able to identify 
either  Fn  or  C4bp  in  amyloid  deposits.  Although  this  negative  result  requires 
confirmation it may indicate that the density of AP molecules in amyloid is insufficient 
for them to express their binding reactivity for Fn and C4bp, or that Fn and C4bp do 
not gain access to amyloid deposits in vivo. 
Fibronectin is both a plasma protein and a constituent of the extracellular matrix 
of connective tissues, as well as being a  major cell surface protein of many different 
cell types (28-31). It seems to have important functions in cell-cell and cell-substratum 
interactions and to participate as a nonspecific opsonin in the phagocytic function of 
the  reticuloendothelial system  (28-31).  It  is  intriguing  that  SAP is  the only other 
protein  known  so  far  that  is  both  a  plasma  protein  and  a  normal  constituent  of 
a Baltz,  M.  L.,  F. C. de Beer, A.  Feinstein, and M. B.  Pepys.  Calcium-dependent aggregation of 
human serum amyloid P component. Manuscript submitted for publication. 
4 Baltz,  M. L., S. Holford, and M. B. Pepys.  Studies of the interaction between serum amyloid P 
component and the complement system. Manuscript in preparation. DE BEER ET AL.  1147 
connective tissues. Immunohistochemical staining with anti-SAP at the ultrastructural 
level reveals an  apparently continuous  "layer" of SAP  in  the lamina  rara  interns  of 
vascular basement  membranes  (12)  and on the peripheral microfibrillar mantle of 
elastic fibres throughout the body.  s In contrast to circulating SAP, SAP molecules in 
these tissue situations may be sufficiently closely aligned to express their reactivity for 
Fn.  Although  the  distributions  of Fn  and  of SAP within  tissues  are certainly not 
always coincident, it is possible that there may be a functionally significant interaction 
between cell surface Fn and tissue SAP at sites, such as the capillary wall, where they 
are in juxtaposition. Experiments are in progress to test this hypothesis by investigating 
a possible role for SAP in processes of cell adherence and growth in vitro. 
Summary 
Serum amyloid P component (SAP) is a normal plasma protein, closely related to 
C-reactive protein, which is  deposited together with amyloid fibrils in all forms of 
amyloidosis.  It  is  also a  normal constituent of human  tissues, where it is  found in 
vascular basement membranes and in association with the peripheral microfibrillar 
mantle of elastic fibres throughout the body. Very similar, highly conserved, homol- 
ogous proteins are present  in  the  sera of all  vertebrates in  which  they have been 
sought, and in all cases these proteins display calcium-dependent binding affinity for 
agarose. The physiological function or pathogenetic significance of this reactivity are 
not known but we report here for the first time that  under appropriate conditions 
human  SAP  can  also  bind  certain  serum  glycoproteins.  SAP,  which  had  been 
aggregated either by direct conjugation to CNBr-activated Sepharose beads, or by 
complexing with anti-SAP antibodies immobilized on such beads, selectively took up 
fibronectin and C4-binding protein from whole normal human serum. The reaction 
was calcium dependent and the two ligands were bound independently of each other 
or  of other  serum  constituents.  Experiments  with  isolated  fibronectin  and  SAP 
complexed by anti-SAP-Sepharose indicated that  close association of pairs  of SAP 
molecules was  required for fibronectin to be bound and that each SAP dimer was 
capable of taking up a  single molecule of fibronectin. There was  no evidence that 
SAP in  its native state in the serum was complexed with either fibronectin or C4- 
binding protein. The present findings significantly extend knowledge of the properties 
of SAP and open the way to characterisation of its physiological ligand(s) and thence 
to elucidation of its function. 
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